首页> HemaSphere> Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.

Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Maeve A,O'Reilly

第一单位： University College London Hospital London UK.;University College London Cancer Institute London UK.

作者： Maeve A,O'Reilly ^[1] ; William,Wilson ^[2] ; David,Burns ^[3] ; Andrea,Kuhnl ^[4] ; Frances,Seymour ^[5] ; Ben,Uttenthal ^[6] ; Caroline,Besley ^[7] ; Rajesh,Alajangi ^[7] ; Thomas,Creasey ^[8] ; Shankara,Paneesha ^[3] ; Johnathon,Elliot ^[9] ; Carlos,Gonzalez Arias ^[10] ; Sunil,Iyengar ^[10] ; Matthew R,Wilson ^[11] ; Alison,Delaney ^[12] ; Lourdes,Rubio ^[13] ; Jonathan,Lambert ^[14] ; Khalil,Begg ^[6] ; Stephen,Boyle ^[4] ; Kathleen P L,Cheok ^[14] ; Graham P,Collins ^[15] ; Claire,Roddie ^[1] ; Rod,Johnson ^[5] ; Robin,Sanderson ^[4]

作者单位： University College London Hospital London UK.;University College London Cancer Institute London UK. ^[1] University College London and CRUK Cancer Trials Centre London UK. ^[2] University Hospital Birmingham Birmingham UK. ^[3] Kings College Hospital London UK. ^[4] Leeds Teaching Hospital Leeds UK. ^[5] Cambridge University Hospital Cambridge UK. ^[6] University Hospital Bristol Bristol UK. ^[7] Newcastle upon Tyne Hospitals Newcastle upon Tyne UK. ^[8] The Christie NHS foundation Trust Manchester UK. ^[9] The Royal Marsden Hospital London UK. ^[10] Beatson West of Scotland Cancer Centre Glasgow UK. ^[11] Sheffield Teaching Hospital Sheffield UK. ^[12] Manchester Royal Infirmary Manchester UK. ^[13] University College London Hospital London UK. ^[14] Oxford University Hospital Oxford UK. ^[15]

DOI 10.1002/hem3.87

PMID 38873532

发布时间 2024-06-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

HemaSphere

2024年8卷6期

e87页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

HemaSphere

2024年8卷6期

e87页

检索历史清除

Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.

HemaSphere

相似文献

同项目论文

HemaSphere

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.

HemaSphere

相似文献

同项目论文

HemaSphere

相关期刊

检索历史清除